載入...

Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus

OBJECTIVE: To investigate the long‐term safety and efficacy of intravenous (IV) belimumab plus standard of care (SOC) therapy for systemic lupus erythematosus (SLE) in patients with active, autoantibody‐positive SLE. METHODS: The study was designed as a multicenter, open‐label, continuation study of...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Rheumatol
Main Authors: Wallace, Daniel J., Ginzler, Ellen M., Merrill, Joan T., Furie, Richard A., Stohl, William, Chatham, W. Winn, Weinstein, Arthur, McKay, James D., McCune, W. Joseph, Petri, Michelle, Fettiplace, James, Roth, David A., Ji, Beulah, Heath, Amy
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617785/
https://ncbi.nlm.nih.gov/pubmed/30771238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40861
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!